• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.37% Nasdaq Down0.21%

    Vertex Pharmaceuticals Incorporated (VRTX)

    80.43 Down 1.57(1.91%) 11:40AM EST - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.1

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:132.57
    Median Target:135.00
    High Target:160.00
    Low Target:95.00
    No. of Brokers:21

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Feb 1, 2016JefferiesUpgradeHoldBuy
    Jan 20, 2016Credit SuisseInitiated Outperform
    Oct 30, 2015H.C. WainwrightUpgradeNeutralBuy
    Oct 2, 2015Morgan StanleyUpgradeEqual-WeightOverweight
    Sep 28, 2015ArgusUpgradeHoldBuy
    Sep 16, 2015NomuraInitiated Buy
    Sep 14, 2015BarclaysUpgradeEqual WeightOverweight
    Sep 9, 2015JefferiesInitiated Hold
    Jan 29, 2015Maxim GroupDowngradeBuyHold
    Jan 29, 2015NeedhamDowngradeBuyHold

    More Upgrades & Downgrades for VRTX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy6655

    Data provided by Thomson/First Call

    Currency in USD.